Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
levofloxacin	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Confusion	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
Ms.	O
___	O
is	O
a	O
___	O
year	O
old	O
woman	O
with	O
PMHx	O
of	O
CAD,	O
DM2,	O
HTN,	O
who	O
presented	O
with	O
NSTEMI	O
on	O
___	O
s/p	O
CABG	O
x	O
4(LIMA-LAD	O
seq	O
to	O
___	O
on	O
___,	O
complicated	O
by	O
sternal	O
wound	O
dehiscence	O
and	O
drainage	O
with	O
vac	O
___	O
presenting	O
with	O
confusion	B-Delirium
and	O
agitation.	B-Delirium
She	O
initially	O
presented	O
to	O
___	O
on	O
___	O
following	O
an	O
episode	O
of	O
intractable	O
chest	O
pain	O
and	O
shortness	O
of	O
breath,	O
found	O
to	O
have	O
an	O
NSTEMI.	O
She	O
was	O
started	O
on	O
a	O
heparin	O
drip	O
and	O
cardiac	O
catheterization	O
showed	O
3VD	O
for	O
which	O
she	O
was	O
transferred	O
to	O
___	O
for	O
CABG	O
evaluation.	O
The	O
patient	O
was	O
brought	O
to	O
the	O
OR	O
on	O
___	O
where	O
the	O
patient	O
underwent	O
coronary	O
artery	O
bypass	O
graft	O
x	O
4.	O
Admitted	O
___	O
and	O
discharged	O
to	O
rehab.	O
She	O
re-presented	O
___	O
with	O
sternal	O
wound	O
dehiscence	O
and	O
drainage.	O
She	O
went	O
to	O
OR	O
on	O
___	O
for	O
sternal	O
debridement	O
with	O
vac	O
placement.	O
In	O
the	O
OR,	O
the	O
inferior	O
sternal	O
wound	O
was	O
open	O
and	O
there	O
was	O
loosening	O
of	O
the	O
wires.	O
There	O
was	O
some	O
tunneling	O
that	O
probed	O
to	O
bone,	O
so	O
the	O
presumptive	O
diagnosis	O
of	O
osteomyelitis	O
was	O
made,	O
but	O
it	O
was	O
unclear	O
if	O
the	O
infection	O
truly	O
went	O
deep	O
and	O
was	O
just	O
more	O
superficial.	O
OR	O
swab	O
was	O
positive	O
for	O
Klebsiella	O
and	O
mixed	O
organisms,	O
which	O
were	O
corynebacterium	O
and	O
CoNS	O
per	O
micro	O
lab.	O
She	O
was	O
treated	O
with	O
meropenem	O
given	O
resistance	O
profile	O
and	O
later	O
switched	O
to	O
ertapenem	O
(confirmed	O
ertapenem	O
sensitive).	O
Of	O
note,	O
her	O
___	O
chest	O
CT,	O
she	O
was	O
incidentally	O
noted	O
to	O
have	O
probable	O
right	O
lower	O
lobe	O
and	O
left	O
upper	O
lobe	O
subsegmental	O
pulmonary	O
emboli,	O
and	O
she	O
has	O
been	O
started	O
on	O
warfarin	O
(goal	O
INR	O
___.	O
This	O
admission,	O
patient	O
comes	O
as	O
a	O
transfer	O
from	O
rehab	O
with	O
new	O
onset	O
delusions	B-Delirium
and	O
hallucinations	B-Delirium
x	O
___	O
days.	O
Per	O
report	O
from	O
nurse	O
at	O
rehab	O
patient	O
has	O
had	O
some	O
loose	O
stools,	O
urinary	B-Urinary_incontinence
and	O
fecal	B-Faecal_incontinence
incontinence,	B-Faecal_incontinence
nausea/vomiting,	O
and	O
decreased	O
PO	O
intake.	O
Arrived	O
via	O
___	O
due	O
to	O
concern	O
for	O
safety.	O
Notably,	O
the	O
patient's	O
most	O
recent	O
OPAT	O
visit	O
was	O
on	O
___.	O
There,	O
patient	O
reported	O
overall	O
doing	O
well	O
until	O
the	O
prior	O
___	O
days	O
when	O
she	O
has	O
noticed	O
increased	O
pain	O
in	O
her	O
chest	O
wall	O
and	O
back.	O
She	O
denied	O
any	O
shortness	O
of	O
breath	O
or	O
fever	O
although	O
the	O
notes	O
from	O
the	O
rehab	O
suggested	O
that	O
she	O
was	O
started	O
on	O
levofloxacin	O
for	O
treatment	O
of	O
possible	O
pneumonia	B-Lower_respiratory_tract_infection
as	O
CXR	O
showed	O
"lower	O
lobe	O
infiltrate	O
vs.	O
atelectasis."	O
Her	O
symptoms	O
included:	O
-	O
Hallucinations	B-Delirium
which	O
include	O
children	O
running	O
around	O
the	O
room,	O
thinking	O
that	O
her	O
mother	O
died	O
recently	O
even	O
though	O
she	O
died	O
___	O
years	O
ago	O
-	O
Paranoia,	B-Delirium
feeling	O
that	O
people	O
are	O
talking	O
about	O
her,	O
accusatory	O
behavior	O
-	O
Poor	O
safety	O
awareness,	O
rinsing	O
wound	O
with	O
toilet	O
water	O
Usually	O
ambulates	B-Mobile_with_assistance
with	O
1	O
x	O
assist.	B-Mobile_with_assistance
No	O
recent	O
falls.	O
Past	O
Medical	O
History:	O
Past	O
Medical	O
History:	O
-	O
Coronary	O
artery	O
disease	O
(CABG	O
x	O
___	O
-	O
Hypertension	O
-	O
T2DM	O
-	O
Hyperlipidemia	O
-	O
Osteoporosis	O
-	O
Dementia	B-Dementia
PSH:	O
___	O
at	O
___	O
1.	O
Coronary	O
artery	O
bypass	O
graft	O
x	O
4	O
2.	O
Skeletonized	O
left	O
internal	O
mammary	O
artery	O
sequential	O
grafting	O
to	O
the	O
diagonal	O
and	O
the	O
left	O
anterior	O
descending	O
artery.	O
3.	O
Skeletonized	O
in	O
situ	O
right	O
internal	O
mammary	O
artery	O
graft	O
to	O
the	O
obtuse	O
marginal	O
artery.	O
4.	O
Long	O
saphenous	O
vein	O
graft	O
to	O
posterior	O
descending	O
artery.	O
-tonsillectomy,	O
aged	O
___	O
Social	O
History:	O
___	O
Family	O
History:	O
-No	O
family	O
history	O
of	O
cardiac	O
disease.	O
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
EXAM:	O
========================	O
VITALS:	O
97.4	O
109/58	O
99	O
17	O
92Ra	O
___:	O
Sleeping	O
but	O
rousable	O
to	O
touch,	O
unable	O
to	O
respond	O
to	O
questions	O
HEENT:	O
Sclerae	O
anicteric	O
CV:	O
Regular	O
rate	O
and	O
rhythm,	O
normal	O
S1	O
+	O
S2,	O
no	O
murmurs,	O
rubs,	O
gallops	O
Lungs:	O
Clear	O
to	O
auscultation	O
bilaterally	O
although	O
diminished	O
at	O
left	O
base	O
Abdomen:	O
Soft,	O
non-tender,	O
non-distended	O
GU:	O
No	O
foley	O
Ext:	O
Warm,	O
well	O
perfused,	O
2+	O
pulses,	O
no	O
clubbing,	O
cyanosis	O
or	O
edema	O
Skin:	O
Warm,	O
dry;	O
large	O
wound	O
on	O
anterior	O
chest	O
with	O
wound	O
vac	O
in	O
place,	O
no	O
surrounding	O
purulence	O
or	O
erythema	O
Neuro:	O
Moving	O
all	O
limbs	O
equally	O
and	O
well	O
DISCHARGE	O
PHYSICAL	O
EXAM:	O
========================	O
VITALS:24	O
HR	O
Data	O
(last	O
updated	O
___	O
@	O
1146)	O
Temp:	O
98.5	O
(Tm	O
98.5),	O
BP:	O
128/73	O
(120-166/73-91),	O
HR:	O
71	O
(71-82),	O
RR:	O
18	O
(___),	O
O2	O
sat:	O
97%	O
(95-100),	O
O2	O
delivery:	O
Ra,	O
Wt:	O
140	O
lb/63.5	O
kg	O
___:	O
Lying	O
in	O
bed;	O
calm	O
and	O
attentive	O
HEENT:	O
PERRL,	O
no	O
rhinorrhea	O
CV/Pulm:	O
Breathing	O
symmetric	O
and	O
non-labored;	O
no	O
abnormal	O
work	O
of	O
breathing	O
Wound:	O
Pink	O
granulation	O
tissue	O
throughout	O
with	O
the	O
exception	O
of	O
~1cm	O
area	O
on	O
inferior	O
sternum,	O
which	O
is	O
whiter	O
in	O
color;	O
no	O
purulent	O
discharge	O
or	O
surrounding	O
erythema	O
(assessed	O
on	O
___.	O
Abdomen:	O
Soft,	O
non-tender,	O
non-distended	O
Ext:	O
wwp	O
Skin:	O
Warm,	O
dry;	O
Neuro:	O
AAOx3.	B-Delirium
EOM	O
grossly	O
intact.	O
Moving	O
all	O
limbs	O
equally.	O
Pertinent	O
Results:	O
ADMISSION	O
LABS:	O
================	O
___	O
01:40AM	O
BLOOD	O
WBC-7.9	O
RBC-2.99*	O
Hgb-8.1*	O
Hct-26.1*	O
MCV-87	O
MCH-27.1	O
MCHC-31.0*	O
RDW-16.2*	O
RDWSD-51.5*	O
Plt	O
___	O
___	O
01:40AM	O
BLOOD	O
Neuts-54.5	O
___	O
Monos-12.0	O
Eos-7.2*	O
Baso-0.4	O
Im	O
___	O
AbsNeut-4.32	O
AbsLymp-2.02	O
AbsMono-0.95*	O
AbsEos-0.57*	O
AbsBaso-0.03	O
___	O
01:40AM	O
BLOOD	O
___	O
PTT-33.7	O
___	O
___	O
01:40AM	O
BLOOD	O
Plt	O
___	O
___	O
01:40AM	O
BLOOD	O
Glucose-90	O
UreaN-9	O
Creat-0.7	O
Na-140	O
K-5.0	O
Cl-109*	O
HCO3-21*	O
AnGap-10	O
___	O
01:40AM	O
BLOOD	O
ALT-8	O
AST-17	O
AlkPhos-77	O
TotBili-0.2	O
___	O
01:40AM	O
BLOOD	O
Albumin-3.4*	O
___	O
01:40AM	O
BLOOD	O
Lactate-1.8	O
IMAGING:	O
========	O
___	O
Imaging	O
CHEST	O
(SINGLE	O
VIEW)	O
Right	O
PICC	O
line	O
tip	O
is	O
difficult	O
to	O
definitively	O
visualized,	O
however	O
appears	O
to	O
be	O
in	O
the	O
lower	O
SVC.	O
Worsening	O
retrocardiac	O
opacity	O
may	O
represent	O
worsening	O
atelectasis	O
or	O
superimposed	O
pneumonia	B-Lower_respiratory_tract_infection
in	O
appropriate	O
clinical	O
setting.	O
Persistent	O
moderate	O
left	O
pleural	O
effusion,	O
which	O
may	O
be	O
loculated.	O
___	O
Imaging	O
CT	O
HEAD	O
W/O	O
CONTRAST	O
No	O
evidence	O
for	O
acute	O
intracranial	B-Intracranial_haemorrhage
abnormalities.	B-Intracranial_haemorrhage
___HEST	O
W/CONTRAST	O
IMPRESSION:	O
Multifocal	O
demineralization	O
of	O
the	O
postoperative	O
sternum,	O
suggesting	O
osteomyelitis.	O
MRI	O
recommended	O
for	O
more	O
precise	O
localization.	O
Trace	O
left	O
pleural	O
effusion,	O
minimally	O
larger	O
compared	O
to	O
prior	O
study,	O
however	O
still	O
very	O
small,	O
with	O
no	O
evidence	O
of	O
loculations.	O
This	O
is	O
likely	O
secondary	O
to	O
the	O
persistent	O
left	O
lower	O
lobe	O
atelectasis	O
which,	O
in	O
association	O
with	O
persistent	O
elevation	O
of	O
the	O
left	O
hemidiaphragm	O
could	O
be	O
due	O
to	O
left	O
phrenic	O
nerve	O
dysfunction.	O
Consider	O
ultrasound	O
evaluation	O
for	O
better	O
assessment.	O
No	O
current	O
filling	O
defects	O
in	O
the	O
left	O
upper	O
lobe	O
and	O
right	O
lower	O
lobes.	O
Stable	O
3	O
mm	O
nodule	O
in	O
the	O
left	O
apex.	O
Follow-up	O
as	O
recommended	O
below.	O
RECOMMENDATION(S):	O
MRI	O
of	O
the	O
sternum.	O
Phrenic	O
ultrasound.	O
For	O
incidentally	O
detected	O
single	O
solid	O
pulmonary	O
nodule	O
smaller	O
than	O
6	O
mm,	O
no	O
CT	O
follow-up	O
is	O
recommended	O
in	O
a	O
low-risk	O
patient,	O
and	O
an	O
optional	O
CT	O
in	O
12	O
months	O
is	O
recommended	O
in	O
a	O
high-risk	O
patient.	O
See	O
the	O
___	O
___	O
Guidelines	O
for	O
the	O
Management	O
of	O
Pulmonary	O
Nodules	O
Incidentally	O
Detected	O
on	O
CT"	O
for	O
comments	O
and	O
reference:	O
___	O
___	O
Imaging	O
MRI	O
CHEST	O
___	O
W&W/O	O
CON	O
IMPRESSION:	O
1.	O
Severely	O
limited	O
study.	O
Within	O
the	O
limitation,	O
there	O
is	O
edema	O
in	O
the	O
distal	O
sternum,	O
deep	O
to	O
the	O
skin	O
incision	O
site.	O
Proximal	O
sternum	O
is	O
not	O
well	O
visualized.	O
Interpretation	O
is	O
difficult	O
due	O
to	O
severe	O
technical	O
limitation,	O
however	O
findings	O
are	O
suspicious	O
for	O
osteomyelitis.	O
2.	O
Small	O
fluid-filled	O
bony	O
gap	O
is	O
identified	O
in	O
the	O
distal	O
sternum	O
measuring	O
1.8	O
cm	O
in	O
length	O
and	O
0.4	O
cm	O
in	O
width.	O
3.	O
Within	O
the	O
limitation,	O
soft	O
tissue	O
edema	O
and	O
enhancement	O
is	O
identified	O
along	O
the	O
deep	O
surface	O
of	O
the	O
sternum	O
in	O
the	O
anterior	O
mediastinum.	O
No	O
fluid	O
collection	O
is	O
identified.	O
DISCHARGE	O
LABS:	O
===============	O
___	O
06:35AM	O
BLOOD	O
WBC-9.7	O
RBC-3.80*	O
Hgb-10.1*	O
Hct-33.1*	O
MCV-87	O
MCH-26.6	O
MCHC-30.5*	O
RDW-16.2*	O
RDWSD-51.1*	O
Plt	O
___	O
___	O
07:40AM	O
BLOOD	O
Glucose-131*	O
UreaN-9	O
Creat-0.7	O
Na-144	O
K-4.5	O
Cl-106	O
HCO3-25	O
AnGap-13	O
___	O
07:40AM	O
BLOOD	O
Calcium-9.3	O
Phos-2.5*	O
Mg-1.9	O
Brief	O
Hospital	O
Course:	O
=================	O
HOSPITAL	O
COURSE:	O
=================	O
Ms.	O
___	O
is	O
a	O
___	O
year	O
old	O
woman	O
with	O
PMHx	O
of	O
CAD,	O
DM2,	O
HTN,	O
NSTEMI	O
(___)	O
s/p	O
CABG	O
x	O
4(LIMA-LAD	O
seq	O
to	O
___,	O
___	O
___,	O
complicated	O
___	O
by	O
sternal	O
wound	O
dehiscence	O
w/	O
probable	O
osteo	O
(on	O
ertopenem)	O
s/p	O
drainage	O
&	O
vac	O
presenting	O
with	O
confusion	B-Delirium
and	O
agitation	B-Delirium
consistent	O
with	O
delirium	B-Delirium
(now	O
improving)	O
found	O
by	O
imaging	O
to	O
have	O
probable	O
worsening	O
of	O
sternal	O
osteomyelitis.	O
ACUTE/ACTIVE	O
PROBLEMS:	O
======================	O
#	O
Sternal	O
wound	O
infection	O
#	O
Klebsiella	O
osteomyelitis:	O
S/p	O
debridement	O
___,	O
followed	O
by	O
OPAT,	O
on	O
ertapenem	O
outpt	O
with	O
projected	O
end	O
date	O
___.	O
CT	O
chest	O
(___)	O
showed	O
"multifocal	O
demineralization	O
of	O
the	O
postoperative	O
sternum";	O
MR	O
sternum	O
was	O
done	O
to	O
give	O
more	O
information	O
on	O
whether	O
this	O
represented	O
natural	O
remodeling	O
of	O
bone	O
in	O
the	O
setting	O
of	O
sternal	O
osteo	O
vs	O
worsening	O
or	O
uncontrolled	O
osteomyelitis,	O
but	O
was	O
a	O
limited	O
study	O
given	O
sternal	O
wires.	O
Radiology	O
opinion	O
is	O
that	O
CT	O
and	O
MRI	O
imaging	O
suggest	O
osteomyelitis	O
that	O
appears	O
worse	O
than	O
before.	O
However,	O
per	O
ID	O
and	O
Cardiac	O
Surgery,	O
imaging	O
is	O
consistent	O
with	O
remodeling	O
and	O
not	O
necessarily	O
evidence	O
of	O
worsening	O
infection.	O
Per	O
ID,	O
still	O
early	O
for	O
the	O
abx	O
to	O
see	O
significant	O
changes	O
as	O
well.	O
Wound	O
swabbed	O
with	O
vac	O
change	O
___	O
(NGTD).	O
Per	O
Cardiac	O
Surgery,	O
wound	O
was	O
healing	O
well	O
with	O
no	O
visual	O
evidence	O
of	O
infection.	O
She	O
was	O
started	O
on	O
meropenum	O
500mg	O
IV	O
Q6H	O
while	O
inpatient	O
and	O
switched	O
back	O
to	O
ertapenum	O
upon	O
discharge.	O
S/p	O
vac	O
change	O
___.	O
Wound	O
vac	O
to	O
be	O
changed	O
q3	O
days.	O
Next	O
wound	O
vac	O
change	O
to	O
be	O
changed	O
on	O
___.	O
#	O
Delirium:	B-Delirium
-	O
improving	O
Patient	O
presented	O
with	O
waxing	O
and	O
waning	O
attention,	O
paranoia,hallucinations,	B-Delirium
which	O
developed	O
1	O
wk	O
ago	O
and	O
worsened	O
3	O
days	O
ago	O
in	O
context	O
of	O
reduced	O
sleep.	O
Symptoms	O
improved	O
during	O
hospital	O
course.	O
Likely	O
multifactorial	O
iso	O
?infxn,	O
dehydration,	O
polypharmacy.	O
1)Polypharmacy	O
(onset	O
of	O
subacute	O
confusion	B-Delirium
near	O
to	O
when	O
started	O
on	O
levofloxacin	O
10	O
days	O
ago,	O
was	O
on	O
multiple	O
potentially	O
delirium	B-Delirium
exacerbating	O
drugs	O
including	O
oxycodone,	O
amytripyline,	O
metoclopramide,	O
furosemide)	O
2)	O
infection	O
(known	O
wound	O
infection	O
with	O
osteo	O
radiologically	O
worsening	O
[CT	O
___,	O
CRP	O
elevated	O
(50)	O
but	O
downtrending	O
and	O
esr	O
wnl	O
at	O
19,	O
reports	O
of	O
poor	O
wound	O
hygiene)	O
3)	O
dehydration/metabolic	O
iso	O
of	O
Lasix	O
use	O
and	O
diarrhea	O
(currently	O
wnl).	O
Per	O
ID,	O
they	O
suspect	O
that	O
the	O
primary	O
inciting	O
factor	O
was	O
the	O
Levofloxacin	O
use.	O
This	O
medication	O
was	O
added	O
to	O
her	O
medication	O
adverse	O
reaction	O
list.	O
See	O
bellow	O
for	O
the	O
list	O
of	O
medications	O
held.	O
We	O
continued	O
her	O
home	O
donepezil	O
and	O
started	O
her	O
on	O
Remelteon	O
during	O
her	O
hospital	O
course.	O
#	O
Polypharmacy	O
-	O
Held	O
Amitriptyline	O
25	O
mg	O
PO	O
QHS:PRN	O
agitation	B-Delirium
-	O
Held	O
OxyCODONE	O
(Immediate	O
Release)	O
5	O
mg	O
PO	O
Q4H:PRN	O
Pain	O
-	O
Moderate	O
-	O
Held	O
Metoclopramide	O
5	O
mg	O
PO	O
QIDACHS	O
-	O
Held	O
Pantoprazole	O
#	O
Retrocardiac	O
opacity	O
#	O
Left	O
pleural	O
effusion	O
Both	O
present	O
>	O
1	O
month.	O
Effusion	O
is	O
likely	O
secondary	O
to	O
the	O
persistent	O
left	O
lower	O
lobe	O
atelectasis	O
which,	O
in	O
association	O
with	O
persistent	O
elevation	O
of	O
the	O
left	O
hemidiaphragm	O
could	O
be	O
due	O
to	O
left	O
phrenic	O
nerve	O
dysfunction.	O
Possibly	O
from	O
the	O
surgery.	O
#	O
Anemia:	O
Hct	O
this	O
admission	O
26.1	O
down	O
from	O
37.1	O
on	O
___.	O
likely	O
baseline	O
as	O
Hgb	O
similar	O
last	O
admission	O
at	O
___.	O
No	O
clear	O
signs	O
of	O
bleeding	O
such	O
as	O
GI	O
or	O
from	O
wound.	O
Iron	O
studies	O
show	O
iron	O
deficiency	O
anemia.	O
Hgb	O
improving	O
(9.3	O
on	O
___	O
up	O
from	O
8.1	O
on	O
admission).	O
She	O
was	O
started	O
on	O
Ferrous	O
Sulfate	O
325	O
mg	O
PO/NG	O
EVERY	O
OTHER	O
DAY	O
(better	O
effect	O
than	O
daily).	O
Her	O
discharge	O
Hb	O
was:	O
10.1.	O
#	O
CAD	O
s/p	O
CABG	O
-	O
Continued	O
Aspirin	O
EC	O
81	O
mg	O
PO	O
DAILY	O
-	O
Continued	O
Atorvastatin	O
40	O
mg	O
PO	O
QPM	O
-	O
Continued	O
Metoprolol	O
Tartrate	O
75	O
mg	O
PO	O
TID	O
-	O
Continued	O
Isosorbide	O
Mononitrate	O
(Extended	O
Release)	O
30	O
mg	O
PO	O
DAILY	O
#	O
Subsegmental	O
PE:	O
On	O
___	O
chest	O
CT	O
incidentally	O
noted	O
to	O
have	O
probable	O
right	O
lower	O
lobe	O
and	O
left	O
upper	O
lobe	O
subsegmental	O
pulmonary	O
emboli,	O
and	O
she	O
was	O
started	O
on	O
warfarin	O
(goal	O
INR	O
___.	O
Anticoagulation	O
may	O
not	O
be	O
necessary	O
for	O
subsegmental	O
PE	O
but	O
continue	O
as	O
this	O
is	O
a	O
home	O
med.	O
***********	O
#	O
Thrombocytosis	O
Patient	O
presented	O
with	O
platelet	O
count	O
of	O
283	O
and	O
during	O
her	O
hospital	O
course,	O
her	O
platelet	O
counted	O
steadily	O
increased	O
in	O
absence	O
of	O
any	O
other	O
additional	O
lab	O
values	O
or	O
new	O
clinical	O
symptoms.	O
Please	O
continue	O
to	O
monitor.	O
CHRONIC/STABLE	O
PROBLEMS:	O
========================	O
#	O
HTN	O
-	O
Held	O
Furosemide	O
20	O
mg	O
PO	O
DAILY	O
(suspect	O
dehydration)	O
-	O
Continued	O
Losartan	O
Potassium	O
100	O
mg	O
PO	O
DAILY	O
#	O
GERD	O
-	O
Held	O
Pantoprazole	O
20	O
mg	O
PO	O
Q24H	O
-	O
Continue	O
Sucralfate	O
1	O
gm	O
PO	O
QHS	O
#	O
T2DM	O
-	O
ISS	O
-	O
Hold	O
home	O
metformin	O
TRANSITIONAL	O
ISSUES:	O
=====================	O
[	O
]	O
Wound	O
vac	O
to	O
be	O
changed	O
q3	O
days.	O
Next	O
wound	O
vac	O
change	O
to	O
be	O
changed	O
on	O
___.	O
Pressure	O
at	O
-125	O
mmHG.	O
[	O
]	O
Please	O
avoid	O
deliriogenic	B-Delirium
medications	O
or	O
try	O
to	O
start	O
them	O
gradually	O
if	O
needed.	O
Can	O
consider	O
pre-medication	O
with	O
oxycodone	O
2.5mg	O
before	O
her	O
wound	O
vac	O
changes.	O
Her	O
pain	O
was	O
otherwise	O
controlled	O
with	O
acetaminophen	O
in	O
the	O
interim.	O
[	O
]	O
Please	O
avoid	O
levofloxacin	O
in	O
the	O
future	O
for	O
this	O
patient.	O
___	O
have	O
been	O
a	O
precipitating	O
factor	O
for	O
her	O
delerium	B-Delirium
[	O
]	O
Please	O
follow	O
up	O
her	O
iron	O
deficiency	O
anemia.	O
[	O
]	O
Please	O
follow	O
up	O
her	O
thrombocytosis	O
[	O
]	O
Please	O
follow	O
up	O
her	O
INR,	O
it	O
has	O
been	O
low	O
during	O
this	O
hospital	O
course	O
and	O
we	O
had	O
to	O
adjust	O
her	O
warfarin	O
dose.	O
Goal	O
INR	O
___.	O
First	O
draw	O
day	O
after	O
discharge.	O
Then	O
please	O
do	O
INR	O
checks	O
___,	O
and	O
___	O
for	O
2	O
weeks	O
then	O
decrease	O
as	O
per	O
rehab	O
[	O
]	O
She	O
will	O
continue	O
her	O
warfarin	O
for	O
a	O
minimum	O
of	O
3	O
months	O
(last	O
day	O
___	O
[	O
]	O
Note	O
we	O
stopped	O
her	O
Furosemide.	O
Monitor	O
weights/volume	O
status.	O
Can	O
restart	O
if	O
weight	O
increases	O
by	O
>3	O
lbs.	O
Discharge	O
wt:	O
140.	O
[	O
]	O
OPAT	O
Antimicrobial	O
Regimen	O
and	O
Projected	O
Duration:	O
-	O
Agent	O
&	O
Dose:	O
Ertapenem	O
1g	O
q	O
24	O
hours	O
-	O
Start	O
Date:	O
___	O
-	O
Projected	O
End	O
Date:	O
___	O
[	O
]	O
WEEKLY:	O
CBC	O
with	O
differential,	O
BUN,	O
Cr,	O
AST,	O
ALT,	O
Total	O
Bili,	O
ALK	O
PHOS,	O
CRP	O
[	O
]	O
For	O
incidentally	O
detected	O
single	O
solid	O
pulmonary	O
nodule	O
smaller	O
than	O
6	O
mm	O
found	O
on	O
chest	O
CT,	O
no	O
CT	O
follow-up	O
is	O
recommended	O
in	O
a	O
low-risk	O
patient,	O
and	O
an	O
optional	O
CT	O
in	O
12	O
months	O
is	O
recommended	O
in	O
a	O
high-risk	O
patient.	O
ALL	O
LAB	O
RESULTS	O
SHOULD	O
BE	O
SENT	O
TO:	O
ATTN:	O
___	O
CLINIC	O
-	O
FAX:	O
___	O
**Medications	O
Started	O
-	O
Ferrous	O
Sulfate	O
325	O
mg	O
PO/NG	O
EVERY	O
OTHER	O
DAY	O
(better	O
effect	O
than	O
daily)	O
**Medications	O
Changed	O
-	O
Acetaminophen	O
1000	O
mg	O
PO/NG	O
TID	O
**Medications	O
Stopped	O
-	O
Amitriptyline	O
25	O
mg	O
PO	O
QHS:PRN	O
agitation	O
-	O
Furosemide	O
20	O
mg	O
PO	O
DAILY	O
---	O
Can	O
restart	O
if	O
wt	O
>3	O
lbs.	O
-	O
Metoclopramide	O
5	O
mg	O
PO	O
QIDACHS	O
-	O
Pantoprazole	O
20	O
mg	O
PO	O
Q24H	O
-	O
Potassium	O
Chloride	O
10mq	O
PO	O
daily	O
-	O
Ondansetron	O
4	O
mg	O
IV	O
Q8H:PRN	O
Nausea/Vomiting	O
-	O
Acidophilus	O
(Lactobacillus	O
acidophilus)	O
oral	O
BID	O
This	O
patient	O
was	O
prescribed,	O
or	O
continued	O
on,	O
an	O
opioid	O
pain	O
medication	O
at	O
the	O
time	O
of	O
discharge	O
(please	O
see	O
the	O
attached	O
medication	O
list	O
for	O
details).	O
As	O
part	O
of	O
our	O
safe	O
opioid	O
prescribing	O
process,	O
all	O
patients	O
are	O
provided	O
with	O
an	O
opioid	O
risks	O
and	O
treatment	O
resource	O
education	O
sheet	O
and	O
encouraged	O
to	O
discuss	O
this	O
therapy	O
with	O
their	O
outpatient	O
providers	O
to	O
determine	O
if	O
opioid	O
pain	O
medication	O
is	O
still	O
indicated.	O
>30	O
min	O
spent	O
on	O
discharge	O
planning	O
including	O
face	O
to	O
face	O
time	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Albuterol	O
Inhaler	O
___	O
PUFF	O
IH	O
Q6H	O
2.	O
Aspirin	O
EC	O
81	O
mg	O
PO	O
DAILY	O
3.	O
Atorvastatin	O
40	O
mg	O
PO	O
QPM	O
4.	O
Furosemide	O
20	O
mg	O
PO	O
DAILY	O
5.	O
Isosorbide	O
Mononitrate	O
(Extended	O
Release)	O
30	O
mg	O
PO	O
DAILY	O
skeletonized	O
arterial	O
grafts	O
6.	O
Losartan	O
Potassium	O
100	O
mg	O
PO	O
DAILY	O
7.	O
MetFORMIN	O
(Glucophage)	O
1000	O
mg	O
PO	O
BID	O
8.	O
Metoprolol	O
Tartrate	O
75	O
mg	O
PO	O
TID	O
9.	O
Potassium	O
Chloride	O
10	O
mEq	O
PO	O
DAILY	O
10.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
11.	O
Ondansetron	O
4	O
mg	O
IV	O
Q8H:PRN	O
Nausea/Vomiting	O
-	O
First	O
Line	O
12.	O
Pantoprazole	O
20	O
mg	O
PO	O
Q24H	O
13.	O
Warfarin	O
2.5	O
mg	O
PO	O
DAILY16	O
pulmonary	O
emboli	O
14.	O
Ertapenem	O
Sodium	O
1	O
g	O
IV	O
1X	O
Klebsiella	O
osteomyelitis	O
15.	O
Acidophilus	O
(Lactobacillus	O
acidophilus)	O
oral	O
BID	O
16.	O
Amitriptyline	O
25	O
mg	O
PO	O
QHS:PRN	O
agitation	B-Delirium
17.	O
Donepezil	O
10	O
mg	O
PO	O
QHS	O
18.	O
Bisacodyl	O
10	O
mg	O
PR	O
QHS:PRN	O
Constipation	B-Constipation
-	O
Second	O
Line	O
19.	O
Sucralfate	O
1	O
gm	O
PO	O
QHS	O
20.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
21.	O
OxyCODONE	O
(Immediate	O
Release)	O
5	O
mg	O
PO	O
Q4H:PRN	O
Pain	O
-	O
Moderate	O
22.	O
Albuterol	O
Inhaler	O
2	O
PUFF	O
IH	O
Q6H	O
23.	O
Metoclopramide	O
5	O
mg	O
PO	O
QIDACHS	O
24.	O
Guaifenesin-Dextromethorphan	O
15	O
mL	O
PO	O
Q6H:PRN	O
cough	O
25.	O
TraZODone	O
100	O
mg	O
PO	O
QHS	O
26.	O
Acetaminophen	O
1000	O
mg	O
PO	O
Q6H	O
Discharge	O
Medications:	O
1.	O
Ferrous	O
Sulfate	O
325	O
mg	O
PO	O
EVERY	O
OTHER	O
DAY	O
2.	O
OxyCODONE	O
(Immediate	O
Release)	O
2.5	O
mg	O
PO	O
ASDIR	O
Dressing	O
changes	O
If	O
needed,	O
can	O
give	O
for	O
dressing	O
change	O
RX	O
*oxycodone	O
5	O
mg	O
0.5	O
(One	O
half)	O
tablet(s)	O
by	O
mouth	O
ASDIR	O
Disp	O
#*15	O
Tablet	O
Refills:*0	O
3.	O
Acetaminophen	O
1000	O
mg	O
PO	O
TID	O
4.	O
Albuterol	O
Inhaler	O
___	O
PUFF	O
IH	O
Q6H	O
5.	O
Albuterol	O
Inhaler	O
2	O
PUFF	O
IH	O
Q6H	O
6.	O
Aspirin	O
EC	O
81	O
mg	O
PO	O
DAILY	O
7.	O
Atorvastatin	O
40	O
mg	O
PO	O
QPM	O
8.	O
Bisacodyl	O
10	O
mg	O
PR	O
QHS:PRN	O
Constipation	B-Constipation
-	O
Second	O
Line	O
9.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
10.	O
Donepezil	O
10	O
mg	O
PO	O
QHS	O
11.	O
Ertapenem	O
Sodium	O
1	O
g	O
IV	O
1X	O
Klebsiella	O
osteomyelitis	O
Duration:	O
1	O
Dose	O
12.	O
Isosorbide	O
Mononitrate	O
(Extended	O
Release)	O
30	O
mg	O
PO	O
DAILY	O
skeletonized	O
arterial	O
grafts	O
13.	O
Losartan	O
Potassium	O
100	O
mg	O
PO	O
DAILY	O
14.	O
MetFORMIN	O
(Glucophage)	O
1000	O
mg	O
PO	O
BID	O
15.	O
Metoprolol	O
Tartrate	O
75	O
mg	O
PO	O
TID	O
16.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
17.	O
Sucralfate	O
1	O
gm	O
PO	O
QHS	O
18.	O
Warfarin	O
2.5	O
mg	O
PO	O
DAILY16	O
pulmonary	O
emboli	O
19.	O
HELD-	O
Acidophilus	O
(Lactobacillus	O
acidophilus)	O
oral	O
BID	O
This	O
medication	O
was	O
held.	O
Do	O
not	O
restart	O
Acidophilus	O
until	O
restarted	O
by	O
a	O
doctor	O
20.	O
HELD-	O
Furosemide	O
20	O
mg	O
PO	O
DAILY	O
This	O
medication	O
was	O
held.	O
Do	O
not	O
restart	O
Furosemide	O
until	O
restarted	O
by	O
a	O
doctor	O
21.	O
HELD-	O
Guaifenesin-Dextromethorphan	O
15	O
mL	O
PO	O
Q6H:PRN	O
cough	O
This	O
medication	O
was	O
held.	O
Do	O
not	O
restart	O
Guaifenesin-Dextromethorphan	O
until	O
restarted	O
by	O
a	O
doctor	O
22.	O
HELD-	O
Metoclopramide	O
5	O
mg	O
PO	O
QIDACHS	O
This	O
medication	O
was	O
held.	O
Do	O
not	O
restart	O
Metoclopramide	O
until	O
restarted	O
by	O
a	O
doctor	O
23.	O
HELD-	O
Ondansetron	O
4	O
mg	O
IV	O
Q8H:PRN	O
Nausea/Vomiting	O
-	O
First	O
Line	O
This	O
medication	O
was	O
held.	O
Do	O
not	O
restart	O
Ondansetron	O
until	O
restarted	O
by	O
a	O
doctor	O
24.	O
HELD-	O
Pantoprazole	O
20	O
mg	O
PO	O
Q24H	O
This	O
medication	O
was	O
held.	O
Do	O
not	O
restart	O
Pantoprazole	O
until	O
restarted	O
by	O
your	O
docotr	O
25.	O
HELD-	O
Potassium	O
Chloride	O
10	O
mEq	O
PO	O
DAILY	O
This	O
medication	O
was	O
held.	O
Do	O
not	O
restart	O
Potassium	O
Chloride	O
until	O
restarted	O
by	O
a	O
doctor	O
___	O
when	O
lasix	O
restarted)	O
26.	O
HELD-	O
TraZODone	O
100	O
mg	O
PO	O
QHS	O
This	O
medication	O
was	O
held.	O
Do	O
not	O
restart	O
TraZODone	O
until	O
restarted	O
by	O
a	O
doctor	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
PRIMARY:	O
=========	O
Osteomyelitis	O
Delirium	B-Delirium
on	O
Dementia	B-Dementia
Iron	O
deficiency	O
anemia	O
SECONDARY:	O
===========	O
Left	O
pleural	O
effusion	O
Sub-segmental	O
PE	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
It	O
was	O
a	O
privilege	O
caring	O
for	O
you	O
at	O
___	O
___.	O
WHY	O
WAS	O
I	O
IN	O
THE	O
HOSPITAL?	O
-	O
You	O
came	O
to	O
the	O
hospital	O
because	O
your	O
acting	O
very	O
confused.	O
WHAT	O
HAPPENED	O
TO	O
ME	O
IN	O
THE	O
HOSPITAL?	O
-	O
We	O
watched	O
you	O
closely	O
and	O
stopped	O
any	O
medication	O
that	O
may	O
have	O
caused	O
this	O
confusion.	B-Delirium
-	O
We	O
gave	O
you	O
some	O
IV	O
fluids	O
to	O
help	O
with	O
some	O
dehydration.	O
-	O
We	O
confirmed	O
that	O
your	O
bone	O
infection	O
was	O
not	O
getting	O
any	O
worse.	O
WHAT	O
SHOULD	O
I	O
DO	O
AFTER	O
I	O
LEAVE	O
THE	O
HOSPITAL?	O
-	O
Continue	O
to	O
take	O
all	O
your	O
medicines	O
and	O
keep	O
your	O
appointments.	O
We	O
wish	O
you	O
the	O
best!	O
Sincerely,	O
Your	O
___	O
Team	O
Followup	O
Instructions:	O
___	O

